Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record with results posted

Targeting Inflammation and Alloimmunity in Heart Transplant Recipients With Tocilizumab (RTB-004)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03644667
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-09-30T00:09:17.932302+00:00
Published At
2026-09-29T00:00:00+00:00
Record Updated At
2026-09-29
Results Posted At
2026-09-29
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Heart Transplant"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-09-29"
protocolSection.identificationModule.nctId
"NCT03644667"
protocolSection.identificationModule.officialTitle
"Targeting Inflammation and Alloimmunity in Heart Transplant Recipients With Tocilizumab (RTB-004)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2026-09-29"

Study condition terms

  • Heart Transplant (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.